Scopus announces launch of the user-friendly Scopus Journal Analyzer

New feature empowers researchers and librarians to evaluate and compare journals using article and citation data

Amsterdam, The Netherlands, May 23, 2008 - Scopus®, the world’s largest abstract and citation database of peer-reviewed literature, today announced the launch of the Scopus Journal Analyzer, a new feature available to all subscribers that enables users to easily evaluate and compare journals using article and citation data. This new feature empowers researchers and librarians by providing them with a quick and transparent overview of the performance of individual journals.

Researchers around the globe are in continuous need of journal comparisons while making important decision – simply whether or not to publish in a particular journal, which journals to track for research purposes, whether to review manuscripts or join editorial boards. The new Scopus Journal Analyzer can greatly simplify this decision-making process, leaving more time for researchers to be productive with their own research.

Dr. Juan Gorraiz from Wien University in Austria says about the Journal Analyzer: “This new feature gives me a good overview of a selection of journals at one time, and provides me with the insights I need before I move on to the detailed analysis. I particularly like being able to calculate my own indicators from my own analysis.”

The Scopus Journal Analyzer enables users to select and compare up to 10 journals simultaneously using three distinct graphical representations of their performance over time. The first displays the total number of citations the selected journals receive over the course of each year. The second shows the number of articles published by each journal over time. The third provides the number of citations received in that year, regardless of the publication date of the cited document, divided by the total number of documents published in that year.

Updated every two months, the Scopus Journal Analyzer will provide accurate, up-to-date journal overviews, allowing users to focus on the actual analysis and make clear, well-informed decisions.

“We are delighted to bring a solution to market that will improve the productivity of its users,” says Niels Weertman, Director Product Management Scopus. “We created this powerful tool with the help of multiple focus groups and user tests, so we are confident it addresses their real needs. Ultimately, the Scopus Journal Analyzer will assist researchers in comparing journals on an equal basis and ensure that librarians are able to allocate their budgets in the most efficient manner possible.”

For further information on Scopus or the Scopus Journal Analyzer, please visit: www.info.scopus.com/journalanalyzer

# # #

About Scopus
Covering the world’s research literature, Scopus is the largest abstract and citation database of peer-reviewed literature and quality Web sources with smart tools to track, analyze and visualize research. Scopus is designed and developed with over 500 users and librarians internationally. Its unique database contains abstracts and references from over 15,000 peer-reviewed journals from 4,000 publishers worldwide, ensuring broad interdisciplinary coverage. In addition, Scopus not only offers users citation information about the articles covered, but also integrates Web and patent searches directly from its clean and simple interface. Direct links to full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool. For more information about Scopus please visit www.info.scopus.com.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact:
Robert Brumfield
Fusion Public Relations
T: + 1 202 898 2000, ext. 109
robert.brumfield@fusionpr.com